We don’t yet know if screening men with BRCA mutations for prostate cancer actually saves lives or improves how they feel long-term.

1

Pro

0

Against

Evidence from Studies

Supporting (1)

1

Community contributions welcome

1

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

Narrative Review

2023 Apr

This study says we still don’t know if checking for prostate cancer early helps BRCA1/2 carriers live longer or feel better, and doctors haven’t agreed on the best way to screen or treat them yet — which is exactly what the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations

Score: 1

DOI: 10.1038/s41585-022-00680-4

Similar Assertions

Having a BRCA1 mutation raises prostate cancer risk, but not as much as having a BRCA2 mutation.

1

0

76%

Germline mutations in BRCA1 and BRCA2 genes confer a significantly elevated risk of developing prostate cancer in men, independent of family history of prostate cancer.

1

0

73%

Men who inherit a faulty BRCA2 gene are 2 to 4 times more likely to get prostate cancer than men without it.

1

0

72%

Standard PSA tests or MRI scans aren’t good enough on their own to find dangerous prostate cancers in men with BRCA mutations—they need better ways to tell who’s really at risk.

1

0

71%